… In 2014, the first α-Syn-based antibody therapeutic candidate entered in clinical trial. In this
… Approved PD therapies are symptomatic, and so far, there are no therapeutic approaches to …

… In this review, we highlight the challenges for the therapeutic application of lipid-lowering
treatment strategies in CKD and discuss why treatment strategies used in the general …

… of dyserythropoiesis will continue to be clarified, collaboration with bioengineering of
treatments acting specifically at the protein domain level will continue to provide new therapies in …

… In a first step we therefore compared the clinical benefits obtained with a CI therapy protocol
that employed reduced daily training intervals with the signature CI therapy intervention [71]. …

… answered by dedicated randomized clinical trials due to … therapy. Therefore, in order to
maximize the effect of a patient-centered approach and exploit the benefits of combination therapy…

… therapies have been approved and for those currently in clinical development demonstrate
that these therapies … by miRNAs that is a consideration for therapeutic development of miRNA …

… As a result, maximum therapeutic effect and minimum toxic effects can be achieved [3]. So,
due to these reasons, nowadays, researchers are mainly focusing their research on the …

… Foundational tenants to the wilderness therapy approach are the use of outdoor living,
wilderness skills, and group dynamics to not only address personal problems and destructive …

… of any one of them from a clinical sample should warrant careful consideration of the animal's
need for antimicrobial therapy based on history and clinical signs. Anecdotally, another …

Although the clinical outcomes of cell therapy trials have not met initial expectations, emerging
evidence suggests that injury-mediated tissue damage might benefit from the delivery of …